Search

Author/Creator Howlett, Christina

1. Comparable outcomes in chronic lymphocytic leukaemia (CLL) patients treated with reduced‐dose ibrutinib: results from a multi‐centre study. (21st February 2017)

Authors:
Mato, Anthony R.; Timlin, Colleen; Ujjani, Chaitra; Skarbnik, Alan; Howlett, Christina; Banerjee, Rahul; Nabhan, Chadi; Schuster, Stephen J.
Journal:
British journal of haematology
Issue:
Volume 181:Number 2(2018)
Page Start:
259
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Front‐line, dose‐escalated immunochemotherapy is associated with a significant progression‐free survival advantage in patients with double‐hit lymphomas: a systematic review and meta‐analysis. (24th April 2015)

Authors:
Howlett, Christina; Snedecor, Sonya J.; Landsburg, Daniel J.; Svoboda, Jakub; Chong, Elise A.; Schuster, Stephen J.; Nasta, Sunita Dwivedy; Feldman, Tatyana; Rago, Allison; Walsh, Kristy M.; Weber, Scott; Goy, Andre; Mato, Anthony
Journal:
British journal of haematology
Issue:
Volume 170:Number 4(2015:Aug.)
Page Start:
504
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Outcomes and Toxicities of Programmed Death‐1 (PD‐1) Inhibitors in Hodgkin Lymphoma Patients in the United States: A Real‐World, Multicenter Retrospective Analysis. (19th December 2018)

Authors:
Bair, Steven M.; Strelec, Lauren E.; Feldman, Tatyana A.; Ahmed, Gulrayz; Armand, Philippe; Shah, Nirav N.; Singavi, Arun N.; Reddy, Nishitha; Khan, Nadia; Andreadis, Charalambos; Vu, Khoan; Huntington, Scott F.; Giri, Smith; Ujjani, Chaitra; Howlett, Christina; Faheem, Malik; Youngman, Matthew R...
Journal:
Oncologist
Issue:
Volume 24:Number 7(2019)
Page Start:
955
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Outcomes in patients with aggressive B‐cell non‐Hodgkin lymphoma after intensive frontline treatment failure. Issue 2 (30th September 2019)

Authors:
Ayers, Emily C.; Li, Shaoying; Medeiros, L. Jeffrey; Bond, David A.; Maddocks, Kami J.; Torka, Pallawi; Mier Hicks, Angel; Curry, Madeira; Wagner‐Johnston, Nina D.; Karmali, Reem; Behdad, Amir; Fakhri, Bita; Kahl, Brad S.; Churnetski, Michael C.; Cohen, Jonathon B.; Reddy, Nishitha M.; Modi, Dipe...
Journal:
Cancer
Issue:
Volume 126:Issue 2(2020)
Page Start:
293
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Reduced‐dose fludarabine, cyclophosphamide, and rituximab (FCR‐Lite) plus lenalidomide, followed by lenalidomide consolidation/maintenance, in previously untreated chronic lymphocytic leukemia. Issue 6 (30th March 2015)

Authors:
Mato, Anthony R.; Foon, Kenneth A.; Feldman, Tatyana; Schuster, Stephen J.; Svoboda, Jakub; Chow, Kar Fai; Valentinetti, Marisa; Mrkulic, Mary; Azzollini, Kelly; Gadaleta, Gabriella; Bhattacharyya, Pritish K.; Zenreich, Joshua; Pascual, Lauren‐Nicole; Yannotti, Kara; Kdiry, Sabrina; Howlett, Chri...
Journal:
American journal of hematology
Issue:
Volume 90:Issue 6(2015:Jun.)
Page Start:
487
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Rituximab, cyclophosphamide-fractionated, vincristine, doxorubicin and dexamethasone alternating with rituximab, methotrexate and cytarabine overcomes risk features associated with inferior outcomes in treatment of newly diagnosed, high-risk diffuse large B-cell lymphoma. Issue 12 (December 2013)

Authors:
Mato, Anthony; Feldman, Tatyana; Zielonka, Tania; Singavi, Arun; Gadaletta, Gabriella; Waksmundzki, Kathryn; Bhattacharyya, Pritish; Chow, Kar Fai; Yang, Xiao; Panush, David; Agress, Harry; Rosario, Maria; Howlett, Christina; Pecora, Andrew; Goy, Andre
Journal:
Leukemia & lymphoma
Issue:
Volume 54:Issue 12(2013:Dec.)
Page Start:
2606
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗